A Dominant Negative Erythropoietin (EPO) Receptor Inhibits EPO-Dependent Growth and Blocks F-gp55-Dependent Transformation

REFERENCES

• Amaya, E., T. J. Musci, and M. W. Kirschner. 1991. Expression of a dominant negative mutant of the FGF receptor disrupts mesoderm formation in Xenopus embryos. Cell 66:257–270.
   PubMed Web of Science ®Google Scholar
• Ben-David, Y., and A. Bernstein. 1991. Friend virus-induced erythroleukemia and the multistage nature of cancer. Cell 66:831–834.
   PubMed Web of Science ®Google Scholar
• Brakebusch, C., Y. Nophar, O. Kemper, H. Engelmann, and D. Wallach. 1992. Cytoplasmic truncation of the p55 tumor necrosis factor (TNF) receptor abolishes signalling, but not induced shedding of the receptor. EMBO J. 11:943–950.
   PubMedGoogle Scholar
• Carroll, M. P., J. L. Spivak, M. McMahon, N. Weich, U. R. Rapp, and W. S. May. 1991. Erythropoietin induces Raf-1 activation and Raf-1 is required for erythropoietin-mediated proliferation. J. Biol. Chem. 266:14964–14969.
   PubMed Web of Science ®Google Scholar
• Casadevall, N., C. Lacombe, O. Muller, S. Gisselbrecht, and P. Mayeux. 1991. Multimeric structure of the membrane erythropoietin receptor of murine erythroleukemia cells. J. Biol. Chem. 266:16015–16020.
   PubMedGoogle Scholar
• Chardin, P., J. H. Camonis, N. W. Gale, L. V. Aelst, J. Schlessinger, M. H. Wigler, and D. Bar-Sagi. 1993. Human Sosl: a guanine nucleotide exchange factor for Ras that binds to Grb2. Science 260:1338–1343.
   PubMed Web of Science ®Google Scholar
• Cunningham, B. C., M. Ultsch, A. M. De Vos, M. G. Mulkerrin, K. R. Clauser, and J. A. Wells. 1991. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 254:821–825.
   PubMed Web of Science ®Google Scholar
• Cutler, R. L., L. Liu, J. E. Damen, and G. Krystal. 1993. Multiple cytokines induce the tyrosine phosphorylation of She and its association with Grb2 in hematopoietic cells. J. Biol. Chem. 268:21463–21465.
   PubMed Web of Science ®Google Scholar
• Damen, J., A. L.-F. Mui, P. Hughes, K. Humphries, and G. Krystal. 1992. Erythropoietin-induced tyrosine phosphorylation events in a high erythropoietin receptor-expressing lymphoid cell line. Blood 80:1923–1932.
   PubMed Web of Science ®Google Scholar
• Damen, J. E., L. Liu, R. L. Cutler, and G. Krystal. 1993. Erythropoietin stimulates the tyrosine phosphorylation of She and its association with Grb2 and a 145-kD tyrosine phosphorylated protein. Blood 82:2296–2303.
   PubMedGoogle Scholar
• Damen, J. E., A. L.-F. Mui, L. Puil, T. Pawson, and G. Krystal. 1993. Phosphatidylinositol 3-kinase associates, via its Src homology 2 domains, with the activated erythropoietin receptor. Blood 81:3204–3210.
   PubMed Web of Science ®Google Scholar
• D'Andrea, A. D., H. F. Lodish, and G. G. Wong. 1989. Expression cloning of the murine erythropoietin receptor. Cell 57:277–285.
   PubMed Web of Science ®Google Scholar
• D'Andrea, A. D., A. Yoshimura, H. Youssoufian, L. I. Zon, J.-W. Koo, and H. F. Lodish. 1991. The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains. Mol. Cell. Biol. 11:1980–1987.
   PubMed Web of Science ®Google Scholar
• De Vos, A., M. Ultsch, and A. Kossiakoff. 1992. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255:306–312.
   PubMed Web of Science ®Google Scholar
• Dusanter-Fourt, I. N. C., C. Lacombe, O. Muller, C. Billat, S. Fischer, and P. Mayeux. 1992. Erythropoietin induces the tyrosine phosphorylation of its own receptor in human erythropoietin-responsive cells. J. Biol. Chem. 267:10670–10675.
   PubMed Web of Science ®Google Scholar
• Ferro, F., S. L. Kozak, M. E. Hoatlin, and D. Kabat. 1993. Cell surface site for mitogenic interaction of erythropoietin receptors with the membrane glycoprotein encoded by Friend erythroleukemia virus. J. Biol. Chem. 268:5741–5747.
   PubMedGoogle Scholar
• Fukunaga, R., E. Ishizaka-Ikeda, C.-X. Pan, Y. Seto, and S. Nagata. 1991. Functional domains of the granulocyte colony-stimulating factor receptor. EMBO J. 10:2855–2865.
   PubMed Web of Science ®Google Scholar
• Hanazono, Y., S. Chiba, K. Sasaki, H. Mano, Y. Yazaki, and H. Hirai. 1993. Erythropoietin induces tyrosine phosphorylation and kinase activity of the c-fps/fes proto-oncogene product in human erythropoietin-responsive cells. Blood 81:3193–3196.
   PubMed Web of Science ®Google Scholar
• Hatakeyama, M., H. Mori, T. Doi, and T. Taniguchi. 1989. A restricted cytoplasmic region of IL-2 receptor β chain is essential for growth signal transduction but not for ligand binding and internalization. Cell 59:837–845.
   PubMed Web of Science ®Google Scholar
• He, T.-C., H. Zhuang, N. Jiang, M. D. Waterfield, and D. M. Wojchowski. 1993. Association of the p85 regulatory subunit of phosphatidylinositol 3-kinase with an essential erythropoietin receptor subdomain. Blood 82:3530–3538.
   PubMedGoogle Scholar
• Hoatlin, M. E., S. L. Kozak, F. Lilly, A. Chakraborti, C. A. Kozak, and D. Kabat. 1990. Activation of erythropoietin receptors by Friend viral gp55. Proc. Natl. Acad. Sci. USA 87:9985–9989.
   PubMed Web of Science ®Google Scholar
• Kashles, O., Y. Yarden, R. Fischer, A. Ullrich, and J. Schlessinger. 1991. A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization. Mol. Cell. Biol. 11:1454–1463.
   PubMed Web of Science ®Google Scholar
• Li, J., A. D. D'Andrea, H. Lodish, and D. Baltimore. 1990. Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor. Nature (London) 343:762–764.
   PubMed Web of Science ®Google Scholar
• Lowenstein, E. J., R. J. Daly, A. G. Batzer, W. Li, B. Margolis, R. Lammers, A. Ullrich, E. Y. Skolnik, D. Bar-Sagi, and J. Schlessinger. 1992. The SH2 and SH3 domain-containing protein Grb2 links receptor tyrosine kinases to Ras signalling. Cell 70:431–442.
   PubMed Web of Science ®Google Scholar
• Mayeux, P., I. Dusanter-Fourt, O. Muller, P. Mauduit, M. Sabbah, B. Druker, W. Vainchenker, S. Fischer, C. Lacombe, and S. Gisselbrecht. 1993. Erythropoietin induces the association of phosphatidylinositol 3′-kinase with a tyrosine-phosphorylated protein complex containing the erythropoietin receptor. Eur. J. Biochem. 216:821–828.
   PubMedGoogle Scholar
• Miller, A. D., and G. J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7:980–989.
   PubMed Web of Science ®Google Scholar
• Miura, O., J. L. Cleveland, and J. N. Ihle. 1993. Inactivation of erythropoietin receptor function by point mutations in a region having homology with other cytokine receptors. Mol. Cell. Biol. 13:1788–1795.
   PubMed Web of Science ®Google Scholar
• Miura, O., A. D'Andrea, D. Kabat, and J. N. Ihle. 1991. Induction of tyrosine phosphorylation by the erythropoietin receptor correlates with mitogenesis. Mol. Cell. Biol. 11:4895–4902.
   PubMed Web of Science ®Google Scholar
• Miura, O., and J. N. Ihle. 1993. Dimer- and oligomerization of the erythropoietin receptor by disulfide bond formation and significance of the region near the WSXWS motif in intracellular transport. Arch. Biochem. Biophys. 306:200–208.
   PubMed Web of Science ®Google Scholar
• Murakami, M., M. Narazaki, M. Hibi, H. Yawata, K. Yasukawa, M. Hamaguchi, T. Taga, and T. Kishimoto. 1991. Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. Proc. Natl. Acad. Sci. USA 88:11349–11353.
   PubMed Web of Science ®Google Scholar
• Mustelin, T., and P. Burn. 1993. Regulation of src family tyrosine kinases in lymphocytes. Trends Biochem. Sci. 18:215–220.
   PubMedGoogle Scholar
• Palacios, R., and M. Steinmetz. 1985. IL-3 dependent mouse clones that express B220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes. Cell 41:727–734.
   PubMed Web of Science ®Google Scholar
• Pelicci, G., L. Lanfrancone, F. Grignani, J. McGlade, F. Cavallo, G. Form, I. Nicoletti, F. Grignani, T. Pawson, and P. G. Pelicci. 1992. A novel transforming protein (She) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70:93–104.
   PubMed Web of Science ®Google Scholar
• Quelle, D. E., and D. M. Wojchowski. 1991. Localized cytosolic domains of the erythropoietin receptor regulate growth signaling and down-modulate responsiveness to granulocyte-macrophage colony-stimulating factor. Proc. Natl. Acad. Sci. USA 88:4801–4805.
   PubMed Web of Science ®Google Scholar
• Quelle, F. W., and D. M. Wojchowski. 1991. Proliferative action of erythropoietin is associated with rapid protein tyrosine phosphorylation in responsive B6SUt.EP cells. J. Biol. Chem. 266:609–614.
   PubMedGoogle Scholar
• Redemann, N., B. Holzmann, T. von Ruden, E. F. Wagner, J. Schlessinger, and A. Ullrich. 1992. Anti-oncogenic activity of signalling-defective epidermal growth factor receptor mutants. Mol. Cell. Biol. 12:491–498.
   PubMed Web of Science ®Google Scholar
• Rozakis-Adcock, M., J. McGlade, G. Mbamalu, G. Pellici, R. Daly, W. Li, A. Batzer, S. Thomas, J. Brugge, P. G. Pelicci, J. Schlessinger, and T. Pawson. 1992. Association of the She and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature (London) 360:689–692.
   PubMed Web of Science ®Google Scholar
• Showers, M. O., J. C. DeMartino, Y. Saito, and A. D. D'Andrea. 1993. Fusion of the erythropoietin receptor and the spleen focus-forming virus gp55 glycoprotein transforms a factor-dependent hematopoietic cell line. Mol. Cell. Biol. 13:739–748.
   PubMedGoogle Scholar
• Showers, M. O., J.-F. Moreau, D. Linnekin, B. Druker, and A. D. D'Andrea. 1992. Activation of the erythropoietin receptor by the Friend spleen focus-forming virus gp55 glycoprotein induces constitutive protein tyrosine phosphorylation. Blood 80:3070–3078.
   PubMedGoogle Scholar
• Torti, M., K. M. Marti, D. A. Altschuler, K. Yamamoto, and E. G. Lapetina. 1992. Erythropoietin induces p21ras activation and pl20GAP tyrosine phosphorylation in human erythroleukemia cells. J. Biol. Chem. 267:8293–8298.
   PubMed Web of Science ®Google Scholar
• Ueno, H., H. Colbert, J. A. Escobedo, and L. T. Williams. 1991. Inhibition of PDGF B receptor signal transduction by coexpression of a truncated receptor. Science 252:844–848.
   PubMedGoogle Scholar
• Watowich, S., A. Yoshimura, G. D. Longmore, D. J. Hilton, Y. Yoshimura, and H. F. Lodish. 1992. Homodimerization and constitutive activation of the erythropoietin receptor. Proc. Natl. Acad. Sci. USA 89:2140–2144.
   PubMed Web of Science ®Google Scholar
• Witthuhn, B. A., F. W. Quelle, O. Silvennoinen, T. Yi, B. Tang, O. Miura, and J. N. Ihle. 1993. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74:227–236.
   PubMed Web of Science ®Google Scholar
• Yoshimura, A., A. D. D'Andrea, and H. F. Lodish. 1990. Friend spleen focus-forming virus glycoprotein gp55 interacts with the erythropoietin receptor in the endoplasmic reticulum and affects receptor metabolism. Proc. Natl. Acad. Sci. USA 87:4139–4143.
   PubMed Web of Science ®Google Scholar
• Yoshimura, A., G. Longmore, and H. F. Lodish. 1990. Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity. Nature (London) 348:647–649.
   PubMed Web of Science ®Google Scholar